Huseyin Aktug

Huseyin Aktug

Auto-generated profile, based on publicly available information

Huseyin Aktug

Department of Histology and Embryology, Faculty of Medicine, Ege University

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2019 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
BOBerrin Ozdil
Berrin Ozdil
GGGünnur Güler
Günnur Güler
EAEda Acikgoz
Eda Acikgoz
DKDuygu Calik Kocaturk
Duygu Calik Kocaturk
HAHuseyin Aktug
Huseyin Aktug

9 August 2023 in ACS Omega
Verified
Journal Article
Open access
DEDerya Erisik
Derya Erisik
BOBerrin Ozdil
Berrin Ozdil
EAEda Acikgoz
Eda Acikgoz
CACemile Sinem Asker Abdikan
Cemile Sinem Asker Abdikan
TYTaha Kadir Yesin
Taha Kadir Yesin
HAHuseyin Aktug
Huseyin Aktug
Malignant tumors are formed by diverse groups of cancer cells. Cancer stem cells (CSCs) are a subpopulation of heterogeneous cells identified in tumors that have the ability to self-renew and differentiate. Colorectal cancer (CRC), the third most frequent malignant tumor, is progressively being supported by evidence suggesting that CSCs are crucial in cancer development. We aim to identify molecular differences between CRC cells and CRC CSCs, as well as the effects of those differences on cell behavior in terms of migration, EMT, pluripotency, morphology, cell cycle/control, and epigenetic characteristics. The HT-29 cell line (human colorectal adenocarcinoma) and HT-29 CSCs (HT-29 CD133+/CD44+ cells) were cultured for 72 h. The levels of E-cadherin, KLF4, p53, p21, p16, cyclin D2, HDAC9, and P300 protein expression were determined using immunohistochemistry staining. The migration of cells was assessed by employing the scratch assay technique. Additionally, the scanning electron microscopy method was used to examine the morphological features of the cells, and their peripheral/central elemental ratios were compared with the help of EDS. Furthermore, a Muse cell cycle kit was utilized to determine the cell cycle analysis. The HT-29 CSC group exhibited high levels of expression for E-cadherin, p53, p21, p16, cyclin D2, HDAC9, and P300, whereas KLF4 was found to be high in the HT-29. The two groups did not exhibit any statistically significant differences in the percentages of cell cycle phases. The identification of specific CSC characteristics will allow for earlier cancer detection and the development of more effective precision oncology options.

12 September 2023 in Histochemistry and Cell Biology
Verified
Journal Article
Closed access
PDF file
BOBerrin Ozdil
Berrin Ozdil
DCDuygu Calik-Kocaturk
Duygu Calik-Kocaturk
CACisem Altunayar-Unsalan
Cisem Altunayar-Unsalan
EAEda Acikgoz
Eda Acikgoz
FOFatih Oltulu
Fatih Oltulu
HAHuseyin Aktug
Huseyin Aktug

1 September 2021 in Acta Histochemica
Verified
Journal Article
Closed access
BOBerrin Ozdil
Berrin Ozdil
DCDuygu Calik-Kocaturk
Duygu Calik-Kocaturk
CACisem Altunayar-Unsalan
Cisem Altunayar-Unsalan
EAEda Acikgoz
Eda Acikgoz
VGVolkan Gorgulu
Volkan Gorgulu
HAHuseyin Aktug
Huseyin Aktug

5 August 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
BUBensu Rüya Uslu
Bensu Rüya Uslu
BOBerrin Ozdil
Berrin Ozdil
ETEnver Tarhan
Enver Tarhan
SÖSerdar Özçelik
Serdar Özçelik
HAHüseyin Aktuğ
Hüseyin Aktuğ
GGGünnur Güler
Günnur Güler
Cancer stem cells (CSCs) play a central role in melanoma growth, resistance to treatment, and relapse, however, their dynamic regulatory behavior remains poorly understood. Vibrational spectroscopy offers a unique, label-free approach to investigate cellular heterogeneity at the molecular level. Here, we explored the biochemical and regulatory dynamics of CSCs identified by using a time-course design, integrating infrared and Raman spectroscopies with cell cycle analysis and immunocytochemistry targeting the checkpoint proteins p16 and p21. CSCs, non-cancer stem cells (NCSCs), and bulk CHL-1 melanoma cells were monitored at 11, 24, 48, and 72 h. CSCs showed a steady S-phase with an early rise in p16 followed by a subsequent increase in p21 expression, indicating a dynamic state of cell cycle checkpoints. In contrast, NCSCs and CHL-1 cells showed more transient p16/p21 expression and CHL-1 exhibited a marked p16 increase at 24 h. Spectroscopic analysis revealed that CSCs exhibited distinct vibrational profiles, predominantly in the nucleic acid-, protein- and lipid-associated regions. These differences were further supported by principal component and hierarchical clustering analyses, which consistently distinguished CSCs from NCSCs. Our findings underline the potential of vibrational spectroscopy to sensitively detect CSC-specific regulatory patterns and support its use in detecting new therapeutic targets in melanoma.

9 February 2021 in TURKISH JOURNAL OF BIOLOGY
Verified
Journal Article
Open access
EDEda Doğan
Eda Doğan
ZDZekeriya Duzgun
Zekeriya Duzgun
ZYZafer Yildirim
Zafer Yildirim
BOBerrin Ozdil
Berrin Ozdil
HAHüseyin Aktuğ
Hüseyin Aktuğ
VÇVildan Bozok Çeti̇nTaş
Vildan Bozok Çeti̇nTaş
PIKfyve is an evolutionarily conserved lipid and protein kinase enzyme that has pleiotropic cellular functions. The aim of the present study was to investigate the effects of phosphatidylinositol-3-phosphate 5-kinase (PIKfyve) inhibitor, YM201636, on nonsmall cell lung cancer (NSCLC) cells growth, tumorigenicity, and claudin (CLDN) expressions. Three NSCLC cell lines (Calu-1, H1299 and HCC827) were used to compare the effects of YM201636. Cytotoxic effects of YM201636 were analysed using XTT assay. Malignancy potential of cells assesses with wound healing and soft agar colony-forming assays. mRNA and protein expressions of claudins were analysed by qRT-PCR and immunofluorescence staining. Our results revealed that YM201636 inhibited the proliferation and malignancy potential of Calu-1, H1299, and HCC827 cells in a dose-dependent manner. After YM201636 treatment CLDN1, -3 and -5 expressions increased significantly in HCC827 cells. CLDN3 and -5 expressions also significantly increased in Calu1 cell line. YM201636 treatment significantly reduced the CLDN1 and increased the CLDN5 expression in H1299 cells. Immunofluorescence staining of CLDN1, -3 and -5 proteins showed a significant increase after YM201636 treatment. Besides, YM201636 induced EGFR mRNA expression in all NSCLC cell lines. Our results have shown that YM201636 inhibits tumorigenicity of NSCLC cells. Furthermore, estimated glomerular filtration rate (EGFR) pathway is important signalling involved in the regulation of claudins. Understanding the mechanisms of PIKfyve inhibitors may improve cancer treatment particularly for EGFR overactivated NSCLC.